Our data suggest that BRCA1 testing may be justified for families with multiple female breast cancers, breast and ovarian cancer or early-onset breast cancer and BRCA2 testing for families with male breast cancer from Pakistan. This evidence concerns the gene BRCA1 and ovarian carcinoma.